Price alert —
Loading…
Sign in to get a one-time email the moment ABSI crosses your price. Free accounts included.
Sign in / create a free account
AMD Reveals A $6.5 Million Marvell Bet That's Already Soaring
Benzinga
·
70d ago
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
·
78d ago
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
GlobeNewswire Inc.
·
141d ago
Absci to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
·
268d ago
Absci Stock Offers High-Risk AI Biotech Exposure With 110% Upside Forecast
Investing.com
·
281d ago
Computer-Aided Drug Design (CADD) Market Competitive Landscape Report – Towards Healthcare
GlobeNewswire Inc.
·
286d ago
Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration
Benzinga
·
314d ago
Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight
GlobeNewswire Inc.
·
357d ago
Absci Announces Pricing of Public Offering of Common Stock
Benzinga
·
362d ago
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
GlobeNewswire Inc.
·
546d ago
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
GlobeNewswire Inc.
·
560d ago
4 Biotech Stocks With AI, Machine Learning Prowess
Investing.com
·
621d ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The Motley Fool
·
691d ago
Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire Inc.
·
785d ago
The Analyst Verdict: Absci In The Eyes Of 6 Experts
Benzinga
·
798d ago
Absci (ABSI) to Report Q1 Earnings: Here's What to Expect
Zacks Investment Research
·
806d ago
Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
·
810d ago